Acceleron Pharma Inc.
Methods of identifying ActRIIB variants

Last updated:

Abstract:

In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.

Status:
Grant
Type:

Utility

Filling date:

27 Oct 2016

Issue date:

13 Aug 2019